A61K 40/19
Dendritic cells
A61K40/19 (Dendritic cells) appears on 823 US grants and 1,763 published applications in this corpus.
Search patents in A61K- Granted patents
- 823
- Published applications
- 1,763
- Assignees
- 718
- Inventors
- 2,658
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 9 | 10 |
| 2002 | 11 | 55 |
| 2003 | 20 | 68 |
| 2004 | 11 | 84 |
| 2005 | 10 | 54 |
| 2006 | 26 | 74 |
| 2007 | 12 | 46 |
| 2008 | 20 | 76 |
| 2009 | 25 | 63 |
| 2010 | 42 | 82 |
| 2011 | 39 | 65 |
| 2012 | 40 | 61 |
| 2013 | 42 | 80 |
| 2014 | 40 | 61 |
| 2015 | 43 | 76 |
| 2016 | 47 | 70 |
| 2017 | 50 | 81 |
| 2018 | 43 | 77 |
| 2019 | 30 | 77 |
| 2020 | 32 | 77 |
| 2021 | 31 | 79 |
| 2022 | 46 | 90 |
| 2023 | 41 | 75 |
| 2024 | 36 | 81 |
| 2025 | 32 | 58 |
| 2026 | 26 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination immunotherapy15 Sep 2026US 12,735,466 B2The Regents of the University of California
- Trojan circulating tumor cells8 Sep 2026US 12,728,140 B2Astrin Biosciences, Inc.
- T cell receptors specific for a mutant form of the RET oncogene and uses thereof8 Sep 2026US 12,729,370 B2Providence Health & Services - Oregon
- Light-induced cellular production of immune functional extracellular vesicles25 Aug 2026US 12,714,751 B2University of Florida Research Foundation, Inc.
- Dendritic cell vaccination sequential to chemotherapy18 Aug 2026US 12,708,644 B2Excoso a.s.
- Compositions and methods for reducing antigen-specific immunogenicity8 Oct 2026US 2026/0306626 A1The Research Foundation for The State University of New York
- Methods and materials for treating cancer8 Oct 2026US 2026/0306630 A1Mayo Foundation for Medical Education and Research
- Methods of sensitizing tumors to treatment with immune checkpoint inhibitors8 Oct 2026US 2026/0306658 A1University of Florida Research Foundation, Inc.
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Method for modulating the differentiation and functions of human dendritic cells1 Oct 2026US 2026/0297524 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Immunostimulatory nucleic acid molecules for activating dendritic cells265US 6,429,199 B1University of Iowa Research Foundation · 2002
- Maturation of dendritic cells with immune response modifying compounds206US 6,558,951 B13M Innovative Properties Company · 2003
- Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens124US 5,994,126 AThe Rockefeller University · 1999
- Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool110US 8,637,307 B2The Trustees of the University of Pennsylvania · 2014
- Compositions and methods for identifying antigens which elicit an immune response89US 6,500,641 B1Wake Forest University School of Medicine · 2002